Close Menu

influenza

The method can be used to detect reassortments in the viral genome by analyzing large databases of influenza genomes and all segments of the viral genome.

Quest Diagnostics has received 510(k) clearance from the US Food and Drug Administration for its Focus Diagnostics Simplexa Flu A/B and RSV test on the 3M Integrated Cycler.

The Focus Diagnostics Simplexa Flu A/B & RSV test is intended to aid in the detection and discrimination of influenza A, influenza B, and respiratory syncytial virus infections.

GenturaDx has developed a molecular diagnostic system that combines sample preparation and real-time PCR testing on a disposable cartridge in an effort to bring molecular testing to more laboratories at small- and medium-sized hospitals.

The firm has licensed the new signatures that it said provide enhanced sensitivity and specificity for H1N1 specimens.

In a research paper published online this week, the scientists demonstrated that Cepheid's Xpert Flu A panel test represents "a great improvement" over methods currently employed by a majority of clinical labs to detect 2009 H1N1 influenza, but still falls a bit short when compared to the gold standard method.

The new venture also will work with Novartis on accelerating the production of influenza seed strains required for vaccine manufacturing.

Focus and 3M are also developing a version of the influenza A/B/RSV test, as well as a test for herpes simplex virus, that would be suitable for use in moderate-complexity laboratories under the Clinical Laboratory Improvement Amendments act.

The company is developing and validating assays for difficult-to-treat and drug-resistant infectious diseases based primarily on targets, biomarkers, and PCR primers developed at the Translational Genomics Research Institute and Northern Arizona University.

Gen-Probe's Prodesse ProFast+ flu assay; Diatherix's STD and herpes diagnostic panels; Mira Dx's PreOvar test for ovarian cancer risk; Seegene's MagicPlex Sepsis and Anyplex MDR-TB assays.

Pages

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.